Search
Descriptor English: Lorazepam
Descriptor Spanish: Lorazepam
Descriptor lorazepam
Scope note: Benzodiazepina usada como agente ansiolítico, con pocos efectos colaterales. También tiene propiedades hipnóticas, anticonvulsivantes y sobre todo sedantes, que ha sido propuesto como agente preanestésico.
Descriptor Portuguese: Lorazepam
Descriptor French: Lorazépam
Entry term(s): Apo Lorazepam
Apo-Lorazepam
Ativan
Donix
Duralozam
Durazolam
Idalprem
Laubeel
Lorazep Von Ct
Lorazepam Medical
Lorazepam Neuraxpharm
Lorazepam Ratiopharm
Lorazepam-Neuraxpharm
Lorazepam-Ratiopharm
Medical, Lorazepam
Novo Lorazem
Novo-Lorazem
Nu Loraz
Nu-Loraz
Orfidal Wyeth
Sedicepan
Sinestron
Somagerol
Temesta
Tolid
Témesta
Von Ct, Lorazep
WY 4036
WY-4036
WY4036
Wyeth, Orfidal
Tree number(s): D03.633.100.079.080.070.450
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D008140
Scope note: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anticonvulsants
Antiemetics
Hypnotics and Sedatives
Anti-Anxiety Agents
GABA Modulators
Registry Number: O26FZP769L
CAS Type 1 Name: 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-
Previous Indexing: Benzodiazepinones (1974)
Chlorobenzenes (1974)
Public MeSH Note: 84; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83
History Note: 84(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-83
DeCS ID: 8316
Unique ID: D008140
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1984/01/01
Date of Entry: 1974/11/11
Revision Date: 2017/05/24
Lorazepam - Preferred
Concept UI M0012696
Scope note A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Preferred term Lorazepam
Ativan - Narrower
Concept UI M0012697
Preferred term Ativan
Entry term(s) Orfidal Wyeth
Témesta
Wyeth, Orfidal
Tolid - Narrower
Concept UI M0464814
Preferred term Tolid
Donix - Narrower
Concept UI M0464800
Preferred term Donix
Duralozam - Narrower
Concept UI M0464801
Preferred term Duralozam
Entry term(s) Durazolam
Idalprem - Narrower
Concept UI M0464802
Preferred term Idalprem
Laubeel - Narrower
Concept UI M0464803
Preferred term Laubeel
Lorazep Von Ct - Narrower
Concept UI M0464804
Preferred term Lorazep Von Ct
Entry term(s) Von Ct, Lorazep
Lorazepam Medical - Narrower
Concept UI M0464806
Preferred term Lorazepam Medical
Entry term(s) Medical, Lorazepam
Lorazepam-Neuraxpharm - Narrower
Concept UI M0464807
Preferred term Lorazepam-Neuraxpharm
Entry term(s) Lorazepam Neuraxpharm
Lorazepam-Ratiopharm - Narrower
Concept UI M0464808
Preferred term Lorazepam-Ratiopharm
Entry term(s) Lorazepam Ratiopharm
Novo-Lorazem - Narrower
Concept UI M0464809
Preferred term Novo-Lorazem
Entry term(s) Novo Lorazem
Nu-Loraz - Narrower
Concept UI M0464810
Preferred term Nu-Loraz
Entry term(s) Nu Loraz
Sedicepan - Narrower
Concept UI M0464811
Preferred term Sedicepan
Sinestron - Narrower
Concept UI M0464812
Preferred term Sinestron
WY-4036 - Narrower
Concept UI M0353485
Preferred term WY-4036
Entry term(s) WY 4036
WY4036
Apo-Lorazepam - Narrower
Concept UI M0464799
Preferred term Apo-Lorazepam
Entry term(s) Apo Lorazepam
Somagerol - Narrower
Concept UI M0464813
Preferred term Somagerol
Temesta - Narrower
Concept UI M0012698
Preferred term Temesta



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey